Abrocitinib (CIBINQO)

Abrocitinib · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Abrocitinib (CIBINQO), covering 2024-05-31 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India [Phase 3]